CD14 and myeloid sarcoma: In this study, we performed a comprehensive analysis of miRNA expression in three immune populations, namely, CD14<sup>+</sup> monocytes, neutrophils, and CD8<sup>+</sup> T cells, in multiple sclerosis (MS) and type 1 diabetes (T1D), two prototypical AIDs.